![](/img/cover-not-exists.png)
A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer
Michael Friedlander, Kenneth C. Hancock, Danny Rischin, Mark J. Messing, Claude A. Stringer, Gemma M. Matthys, Bo Ma, Jeffrey P. Hodge, Joanne J. LagerVolume:
119
Year:
2010
Language:
english
Pages:
6
DOI:
10.1016/j.ygyno.2010.05.033
File:
PDF, 332 KB
english, 2010